Table 4

Variable	Locoregional Control P value OR (95% CI)	Distant Metastasis Control P value OR (95% CI)	Overall Survival P value OR (95%CI)
Age (< 50 vs. > 50 years)	0.33 0.93 (0.90-1.50)	0.66 1.10 (0.89-2.00)	0.71 0.50 (0.10-2.41)
Cormorbids (Yes vs. No)	0.98 0.88 (0.67-0.97)	0.901.80 (0.79-2.10)	1.00 1.80 (0.79-2.10)
FIGO stage (<IB vs. >IB)	0.75 0.50 (0.10-2.41)	0.02 3.65 (1.81-9.65)	0.01 3.85 (1.91-10.35)
N stage (N0 vs. N1)	0.77 1.10 (0.89-2.00)	0.661.10 (0.89-2.00)	0.56 1.21 (1.10-2.10)
BMI kg/m2 (>30 vs. <30)	0.02 3.45 (1.61-9.45)	0.56 1.10 (0.89-2.00)	0.02 3.65 (1.81-9.65)
Cell type ( Endometroid vs. non Endometroid)	0.48 1.21 (1.10-2.10)	0.60 1.10 (0.89-2.00)	0.77 1.21 (1.10-2.10)
Grade (<G2 vs..G3)	0.23 0.97 (0.95-1.13)	0.90 0.88 (0.67-0.97)	0.23 0.97 (0.95-1.13)
LVI ( no vs. yes)	0.05 3.34 (2.52-10.34)	0.90 0.88 (0.67-0.97)	0.60 1.10 (0.89-2.00)
Adjuvant chemotherapy (No vs. Yes)	0.03 2.21 (1.45-7.85)	0.44 0.93 (0.90-1.50)	0.70 0.50 (0.10-2.41
EBRT dose (45 Gy vs. 50.4)	0.45 0.78 (0.23-2.38)	0.450.78 (0.23-2.38)	0.56 1.10 (0.89-2.00)
Squamous metaplasia (Yes vs. No)	0.85 1.80 (0.79-2.10)	0.400.78 (0.23-2.38)	0.33 0.93 (0.90-1.50)

FIGO= International Federation of Gynecology and Obstetrics, BMI= body mass index, LVI= lymphovascular invasion, EBRT= external beam radiation therapy, G= grade

Table 4: Univariate and multivariate analyses of variables on locoregional control, distant control and overall survival in both treatment sub groups.